• EMA survey identifies gaps in pharma industry's preparedness for Brexit pharmafile
    July 17, 2018
    An EMA survey has identified gaps in the pharmaceutical industry’s preparedness for Brexit, finding that only 58% of market authorisation holders are on track with their regulatory planning in preparation for the UK’s exit from the European Union in March
PharmaSources Customer Service